Artificial Intelligence In Genomics Market Size, Share, Growth, Forecast 2032
Artificial Intelligence In Genomics Market - By Technology (Machine Learning and Computer Vision), By End-User (Pharma and Research), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032-
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 568.1 Million | USD 15365.78 Million | 39.1% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
- 2.2. Artificial Intelligence In Genomics Market: Snapshot
- Chapter 3. Global Artificial Intelligence In Genomics Market– Industry Analysis
- 3.1. Artificial Intelligence In Genomics Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Massive use of next generation sequencing in genomics has resulted in rise in the precision and success of the healthcare sector. Hence, it has become imperative to combine this whule genome sequencing method with machine learning for improving the medical practice as well as improving the knowhow of diseases such as cancer. This will prompt the market growth over 2020-2026.
- 3.2.2. Thriving precision medicine market and need for exact whule genome synthesis has created huge growth avenues for artificial intelligence in genomics industry.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By End-User
- 3.4.2. Market attractiveness analysis By Technology
- Chapter 4. Global Artificial Intelligence In Genomics Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Artificial Intelligence In Genomics Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Technology launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Artificial Intelligence In Genomics Market– End-User Analysis
- 5.1. Global Artificial Intelligence In Genomics Market overview: By End-User
- 5.1.1. Global Artificial Intelligence In Genomics Market share, By End-User , 2019 and 2026
- 5.2. Pharma
- 5.2.1. Global Artificial Intelligence In Genomics Market By Pharma, 2016–2026 (USD Million)
- 5.3. Research
- 5.3.1. Global Artificial Intelligence In Genomics Market By Research, 2016–2026 (USD Million)
- 5.1. Global Artificial Intelligence In Genomics Market overview: By End-User
- Chapter 6. Global Artificial Intelligence In Genomics Market– Technology Analysis
- 6.1. Global Artificial Intelligence In Genomics Market overview: By Technology
- 6.1.1. Global Artificial Intelligence In Genomics Market share, By Technology, 2019 and 2026
- 6.2. Machine Learning
- 6.2.1. Global Artificial Intelligence In Genomics Market By Machine Learning , 2016–2026 (USD Million)
- 6.3. Computer Vision
- 6.3.1. Global Artificial Intelligence In Genomics Market By Computer Vision, 2016–2026 (USD Million)
- 6.1. Global Artificial Intelligence In Genomics Market overview: By Technology
- Chapter 7. Company Profiles
- 7.1. Deep Genomics (Canada)
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Technology Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. IBM (U.S.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Technology Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. FDNA Inc. (U.S.)
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Technology Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Microsoft (U.S.)
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Technology Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Genoox Ltd. (U.S.)
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Technology Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. NVIDIA Corporation (U.S.)
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Technology Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Lifebit (UK)
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Technology Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. DNAnexus Inc. (U.S.).
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Technology Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Diploid (Belgium)
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Technology Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. PrecisionLife Ltd (UK)
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Technology Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Data4Cure Inc. (U.S.)
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Technology Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. MulecularMatch Inc. (U.S.)
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Technology Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Freenome Huldings, Inc. (U.S.)
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Technology Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. SOPHiA GENETICS (U.S.)
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Technology Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. Verge Genomics (U.S.)
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Technology Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.16. Fabric Genomics Inc. (U.S.)
- 7.16.1. Overview
- 7.16.2. Financials
- 7.16.3. Technology Portfolio
- 7.16.4. Business Strategy
- 7.16.5. Recent Development
- 7.17. Cambridge Cancer Genomics (UK)
- 7.17.1. Overview
- 7.17.2. Financials
- 7.17.3. Technology Portfolio
- 7.17.4. Business Strategy
- 7.17.5. Recent Development
- 7.18. BenevulentAI (UK)
- 7.18.1. Overview
- 7.18.2. Financials
- 7.18.3. Technology Portfolio
- 7.18.4. Business Strategy
- 7.18.5. Recent Development
- 7.1. Deep Genomics (Canada)
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Artificial Intelligence In Genomics Market attractiveness, By End-User
6. Global Artificial Intelligence In Genomics Market attractiveness, By Technology
7. Global Artificial Intelligence In Genomics Market Share by End-User ,2019 and 2026 (USD Million)
8. Global Artificial Intelligence In Genomics Market by Pharma ,2016–2026 (USD Million)
9. Global Artificial Intelligence In Genomics Market by Research,2016–2026 (USD Million)
10. Global Artificial Intelligence In Genomics Market Share by Technology ,2019 and 2026 (USD Million)
11. Global Artificial Intelligence In Genomics Market by Machine Learning , and,2016–2026 (USD Million)
12. Global Artificial Intelligence In Genomics Market by Computer Vision,2016–2026 (USD Million)
13. Global Artificial Intelligence In Genomics Market share, by Region, 2019 and 2026
14. North America Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
15. Europe Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
16. Asia Pacific Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
17. Latin America Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
18. The Middle East and Africa Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
Table Of Tables
List of Tables
1. Global Artificial Intelligence In Genomics Market: snapshot
2. Drivers of the Artificial Intelligence In Genomics Market: impact analysis
3. North America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
4. North America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
5. The U.S. Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
6. The U.S. Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
7. Rest of North America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
8. Rest of North America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
9. Europe Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
10. Europe Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
11. UK Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
12. UK Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
13. France Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
14. France Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
15. Germany Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
16. Germany Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
17. Rest of Europe Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
18. Rest of Europe Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
19. Asia Pacific Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
20. Asia Pacific Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
21. China Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
22. China Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
23. Japan Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
24. Japan Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
25. India Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
26. India Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
27. Rest of Asia Pacific Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
28. Rest of Asia Pacific Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
29. Latin America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
30. Latin America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
31. Brazil Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
32. Brazil Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
33. Rest of Latin America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
34. Rest of Latin America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
35. The Middle East and Africa Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
36. The Middle East and Africa Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
37. Saudi Arabia Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
38. Saudi Arabia Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
39. South Africa Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
40. South Africa Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
41. Rest of the Middle East & Africa Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
42. Rest of the Middle East & Africa Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
Methodology
FrequentlyAsked Questions
Massive use of next generation sequencing in genomics has resulted in rise in the precision and success of the healthcare sector. Hence, it has become imperative to combine this whole genome sequencing method with machine learning for improving the medical practice as well as improving the knowhow of diseases such as cancer. This will prompt the market growth over 2024 – 2032.
According to Zion Market Research report, the the global Artificial Intelligence In Genomics Market was valued at USD 568.1 Million in 2023 and is projected to hit USD 15365.78 Million by 2032, with a compound annual growth rate (CAGR) of 39.1% during the forecast period 2024-2032.
North America is likely to make noteworthy contributions towards overall market revenue. The growth of the industry in the sub-continent over the estimated timespan is attributed to surge in the allocation of funds by private firms & public sector for AI research activities to determine or find its myriad uses in the field of genomics. Apart from this, favorable government schemes for promoting the use of precision medicine in the countries such as the U.S. will drive the regional market growth over the assessment period.
The key players profiled in the report include are Deep Genomics (Canada), IBM (U.S.), FDNA Inc. (U.S.), Microsoft (U.S.), Genoox Ltd. (U.S.), NVIDIA Corporation (U.S.), Lifebit (UK), BenevolentAI (UK), Cambridge Cancer Genomics (UK), Fabric Genomics Inc. (U.S.), Verge Genomics (U.S.), SOPHiA GENETICS (U.S.), Freenome Holdings, Inc. (U.S.), MolecularMatch Inc. (U.S.), Data4Cure Inc. (U.S.), PrecisionLife Ltd (UK), Diploid (Belgium), and DNAnexus Inc. (U.S.).
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed